 SCOTTSDALE, Ariz., Aug. 18, 2021 PRNewswire -- Electromedical Technologies, Inc. OTCQB: EMED the Company, a pioneer in the development and production of bioelectronic devices designed to relieve chronic, intractable and acute pains by using frequencies and electro-modulation, is pleased to announce that it recorded strong results for the second quarter of 2021, ending June 30, as compared to the same period in 2020. 